Specialty Pharmacy

Several pharmaceutical market trends are likely to affect pharmacists' practice this year.

Several factors influence survival among patients with both HIV and Hodgkin’s lymphoma.

Discovery can help predict progression to metastatic cancer.

Sarilumab is a human monoclonal antibody that targets the IL-6 receptor.

Test can better analyze the potential disease progression of skin cancer.

B cells can contribute to abnormal immune responses in MS patients.

Researchers compare efficacy and side effects of different psoriatic arthritis treatment options.

Patients in New York City can now have their prescription drugs delivered to them on demand.

Tricare to increase its copay for prescription drugs starting February 1, 2016.

Burdened by the symptoms of hepatitis C, an Australian man faced an uncertain future before new antiviral drugs offered hope.

Marc O'Connor, chief operating officer of Curant Health, discusses potential changes patients of specialty pharmacies may experience in the near future.

Procedure targets changes in the mucosa that might indicate colorectal cancer among patients with inflammatory bowel disease.

Study emphasizes need for long-term communication between physicians and patients regarding prostate cancer screening.

Research finds self-management of RA and patient exercise can reduce pain and disability.

Children ages 2 to 17 years will now be allowed to use the Animas Vibe insulin pump and continuous glucose monitoring system for diabetes management.

Patients may be more likely to retain information about their prescribed medications when the pharmacist-patient relationship becomes a 2-way conversation.

Cost of some drugs jump by as much as 20%.

Study finds greater access to Medicaid needed for low income cancer survivors.

Study shows promising results for previously treated or refractory patients with multiple myeloma.

Rate of lung cancer significantly higher in patients with upper lobe pneumonia.

Research explores non-invasive methods to allow for the safe study of cancer progression.

Study finds several common food additives associated with a variety of autoimmune conditions.

Emtricitabine-tenofovir disoproxil fumarate found to be comparable in safety to PrEP.

Implanting tumor samples from skin cancer patients in mice helps target melanoma escape routes.

David Lassen, chief clinical officer at Prime Therapeutics, discusses how high cost hepatitis C drugs have impacted the entire specialty landscape.

Process may lead to better quality liver cells derived from clinical grade stem cells.

Targeting Dicer enzyme may help prevent cancer development.

Study finds that patients prescribed expensive drugs will continue to face high out-of-pocket costs.